Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML

Badder Kattih, MD, Amir Shirvani, Piroska Klement, Abel Martin Garrido, Razif Gabdoulline, Alessandro Liebich, Maximilian Brandes, Anuhar Chaturvedi, PhD, Timon Seeger, Felicitas Thol, Gudrun Gohring, Prof., MD, Brigitte Schlegelberger, MD, Robert Geffers, PhD, David John, Udo Bavendiek, Johann Bauersachs, Arnold Ganser, Joerg Heineke, Michael Heuser

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-143026

Published: 2020

Journal Articles

Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid Leukemia

Anuhar Chaturvedi, PhD, Michelle Maria Araujo Cruz, PhD, Ramya Goparaju, PhD, Razif Gabdoulline, Renate Schottmann, Kerstin Görlich, Arnold Kloos, Felicitas Thol, MD, Robert Geffers, PhD, Dimitrios Mougiakakos, Peter Carmeliet, MD PhD, Arnold Ganser, MD, Michael Heuser, MD

Blood (2018) 132 (Supplement 1): 759.

https://doi.org/10.1182/blood-2018-99-110425

Published: 2018

Journal Articles

Co-Transplantation of CAR-Gene Engineered Precursor T Cells Leads to Suppressed T Cell Development and Increased NK Cell-Based CAR-Mediated Anti-Leukemic Activity

Marcel Maluski, Jessica Herbst, Vanessa Scholl, Rolf Baumann, MD, Niels Heinz, PhD, Robert Geffers, PhD, Johann Meyer, PhD, Andreas Krueger, PhD, Axel Schambach, MD PhD, Martin G. Sauer

Blood (2017) 130 (Supplement 1): 1916.

https://doi.org/10.1182/blood.V130.Suppl_1.1916.1916

Published: 2017

Journal Articles

Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia

Anuhar Chaturvedi, PhD, Charu Gupta, Ramya Goparaju, Razif Gabdoulline, PhD, Stefan Kaulfuss, PhD, Kerstin Görlich, Renate Schottmann, Olaf Panknin, Markus Wagner, PhD, Robert Geffers, PhD, Arnold Ganser, MD, Felicitas Thol, MD, Michael Jeffers, PhD, Andrea Haegebarth, Michael Heuser, MD

Blood (2017) 130 (Supplement 1): 1352.

https://doi.org/10.1182/blood.V130.Suppl_1.1352.1352

Published: 2017

Journal Articles

Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo

Blood (2016) 128 (22): 745.

https://doi.org/10.1182/blood.V128.22.745.745

Published: 2016

Journal Articles

Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2015) 126 (23): 912.

https://doi.org/10.1182/blood.V126.23.912.912

Published: 2015

Journal Articles

FOXR1 Activation in B-Cell Lymphoma

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Stefan Nagel, PhD, Vivien Hauer, Margarete Zaborski, Rose Marie Amini, PhD, Mattias Berglund, PhD, Robert Geffers, PhD, Hans G Drexler, Prof. MD

Blood (2015) 126 (23): 2422.

https://doi.org/10.1182/blood.V126.23.2422.2422

Published: 2015

Journal Articles

The Metabolite R-2-Hydroxyglutarate (R2HG) Collaborates with HoxA9 to Induce Monocytic Leukemia

Anuhar Chaturvedi, PhD, Michelle Maria Araujo Cruz, Nidhi Jyotsana, Amit Sharma, PhD, Ramya Goparaju, Vishwas Sharma, PhD, Adrian Schwarzer, MDPhD, Kerstin Goerlich, Renate Schottmann, Eduard A. Struys, PhD, Erwin E. Jansen, Robert Geffers, PhD, Gudrun Goehring, MD, Felicitas Thol, MD, Arnold Ganser, Michael Heuser, MD

Blood (2014) 124 (21): 366.

https://doi.org/10.1182/blood.V124.21.366.366

Published: 2014

Journal Articles

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

Nils von Neuhoff, PhD, Peter Husemann, PhD, Robert Geffers, PhD, Christiane Walter, M.Sc., Christine von Neuhoff, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Dirk Reinhardt, MD PhD

Blood (2014) 124 (21): 2340.

https://doi.org/10.1182/blood.V124.21.2340.2340

Published: 2014

Journal Articles

BCL6 Overexpression – Regulated By AhR/ARNT and Wild-Type MEF2B – Drives Expression of Germinal Center Markers MYBL1 and LMO2

Hilmar Quentmeier, PhD, Jie Ding, PhD, Willy Dirks, PhD, Stefan Ehrentraut, PhD, Robert Geffers, PhD, Rod AF MacLeod, PhD, Stefan Nagel, PhD, Michaela Scherr, Lea AI Vaas, PhD, Hans G Drexler, Prof. MD

Blood (2014) 124 (21): 865.

https://doi.org/10.1182/blood.V124.21.865.865

Published: 2014

Journal Articles

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

Stefan Ehrentraut, Stefan Nagel, PhD, Michaela Scherr, Bjoern Schneider, Hilmar Quentmeier, PhD, Robert Geffers, PhD, Monika Prochorec-Sobieszek, Rhett P Ketterling, MD, Ryan A Knudson, Andrew L. Feldman, MD, Marshall Kadin, Hans G. Drexler, MD, PhD, Roderick AF MacLeod

Blood (2012) 120 (21): 1567.

https://doi.org/10.1182/blood.V120.21.1567.1567

Published: 2012

Journal Articles

Mutated IDH1 Has 2-Hydroxyglutarate-Independent Functions in Leukemogenesis

Blood (2012) 120 (21): 770.

https://doi.org/10.1182/blood.V120.21.770.770

Published: 2012

Journal Articles

A Variant of Congenital Neutropenia Is Caused by a 3′-UTR Mutation in the Gene Encoding the Endosomal Adaptor Protein p14 ( MAPBPIP ).

Georg Bohn, MD, Anna Allroth, Jens Thiel, MD, Alejandro A. Schäffer, Gudrun Brandes, MD, Erik Glocker, David Teis, PhD, Nicole Taub, Cornelia Zeidler, MD, Robert Geffers, PhD, Jan Buer, MD, Lukas A. Huber, MD/PhD, Karl Welte, MD/PhD, Bodo Grimbacher, MD, Christoph Klein, MD/PhD

Blood (2005) 106 (11): 92.

https://doi.org/10.1182/blood.V106.11.92.92

Published: 2005

Journal Articles

Immunedysregulatory Events in Hodgkin’s Disease.

Christian Koenecke, MD, Robert Geffers, PhD, Wenji Piao, MD, Hunger J. Katrin, Ganser Arnold, MD, Buer Jan, MD, Franzke Anke, MD

Blood (2005) 106 (11): 968.

https://doi.org/10.1182/blood.V106.11.968.968

Published: 2005

Journal Articles

Transcriptional Profiling Reveals a Critical Role for Gfi1 in STAT3-Dependent Dendritic Cell Development and -Function.

Chozhavendan Rathinam, MSc, Robert Geffers, PhD, Raif Yuecel, PhD, Jan Buer, MD, Karl Welte, MD, Tarik Moeroey, PhD, Christoph Klein, MDPhD

Blood (2004) 104 (11): 3555.

https://doi.org/10.1182/blood.V104.11.3555.3555

Published: 2004

Journal Articles

BEX1 , a Marker for Acute Myeloid Leukemia Cell Lines with MLL Rearrangements.

Hilmar Quentmeier, PhD, Wilhelm G. Dirks, PhD, Robert Geffers, PhD, Cord C. Uphoff, PhD, Hans G. Drexler, MD, PhD

Blood (2004) 104 (11): 3013.

https://doi.org/10.1182/blood.V104.11.3013.3013

Published: 2004

NARROW

IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML

Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid Leukemia

Co-Transplantation of CAR-Gene Engineered Precursor T Cells Leads to Suppressed T Cell Development and Increased NK Cell-Based CAR-Mediated Anti-Leukemic Activity

Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia

Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo

Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation

FOXR1 Activation in B-Cell Lymphoma

The Metabolite R-2-Hydroxyglutarate (R2HG) Collaborates with HoxA9 to Induce Monocytic Leukemia

Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing

BCL6 Overexpression – Regulated By AhR/ARNT and Wild-Type MEF2B – Drives Expression of Germinal Center Markers MYBL1 and LMO2

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

Mutated IDH1 Has 2-Hydroxyglutarate-Independent Functions in Leukemogenesis

A Variant of Congenital Neutropenia Is Caused by a 3′-UTR Mutation in the Gene Encoding the Endosomal Adaptor Protein p14 ( MAPBPIP ).

Immunedysregulatory Events in Hodgkin’s Disease.

Transcriptional Profiling Reveals a Critical Role for Gfi1 in STAT3-Dependent Dendritic Cell Development and -Function.

BEX1 , a Marker for Acute Myeloid Leukemia Cell Lines with MLL Rearrangements.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only